Pharmaceuticals, Volume 15, Issue 9
2022 September - 128 articles
Cover Story: Retinoblastoma is a rare, sometimes hereditary, pediatric cancer. Depending on the stage of the disease, different therapeutic protocols are applied. In more advanced forms, surgical removal of the entire globe and its intraocular contents (enucleation) is necessary. In other cases, local treatments (laser, photocoagulation, cryotherapy, etc.) and conventional chemotherapy are used. To overcome the side-effects and reduced efficacy of chemotherapeutic drugs, nanodelivery systems have been developed. They allow for a sustained drug release and manage to reach the target site. This review regards the current use and advances of nanomedicine in the treatment of retinoblastoma, and it investigates nanoparticles containing conventional drugs and natural products. In addition, future developments in retinoblastoma treatment are discussed. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.